Study Summary
This trial will study an intervention to reduce suicide risk in people with psychotic disorders by targeting emotion dysregulation. Measurement and modeling techniques will help inform future suicide prevention research for this high-risk group.
- Suicide
- Psychosis
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: Four months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Treatment As Usual
1 of 2
Dialectical Behavior Therapy - Skill Training
1 of 2
Active Control
Experimental Treatment
68 Total Participants · 2 Treatment Groups
Primary Treatment: Dialectical Behavior Therapy - Skill Training · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any vacancies to join this experiment?
"According to the information posted on clinicaltrials.gov, this research project is still open for recruitment and has been since December 2nd 2022. The data was most recently updated on March 1st of 2023." - Anonymous Online Contributor
How many participants is this trial accommodating?
"Affirmative. The information provided on clinicaltrials.gov demonstrates that this medical experiment is actively looking for new participants. This investigation was put up to the public eye on December 2nd 2022, and has since been updated as of March 1st 2023. 68 individuals are required at one site in order to conduct it properly." - Anonymous Online Contributor